Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xilio Therapeutics (XLO) Non-cash Items (2024 - 2025)

Xilio Therapeutics' Non-cash Items history spans 2 years, with the latest figure at $6.5 million for Q3 2025.

  • For Q3 2025, Non-cash Items rose 6418.51% year-over-year to $6.5 million; the TTM value through Sep 2025 reached $6.5 million, up 6418.51%, while the annual FY2024 figure was $282000.0, N/A changed from the prior year.
  • Non-cash Items for Q3 2025 was $6.5 million at Xilio Therapeutics, up from $4.9 million in the prior quarter.
  • Across five years, Non-cash Items topped out at $6.5 million in Q3 2025 and bottomed at $59000.0 in Q1 2025.